Importantly, CD123 has been reported in CD34 + CD38-Lin- populations from healthy bone marrow (BM) and cord blood (CB) donors, with intensities of expression significantly lower than their AML counterparts (such differences were not observed for other myeloid markers such as CD13 and CD33)14. The gene discussed is IL3RA; the disease is acute myeloid leukemia.